Supplement improves nutrition and stresses caused by examination-associated fasting in patients with liver cirrhosis

Hepatology Research

Volumn 38, Issue 12, 2008, Pages 1178-1185

  Kawaguchi, Takumi ^a   Taniguchi, Eitaro ^a   Itou, Minoru ^a   Mutou, Michiko ^b   Ibi, Ryoko ^b   Shiraishi, Satomi ^b   Okada, Teruyo ^b   Uchida, Yuki ^b   Otsuka, Momoka ^b   Tonan, Tatsuyuki ^a   Fujimoto, Kiminori ^a   Oriishi, Tetsuharu ^a   Tanaka, Suiko ^b   Takakura, Machiko ^b   Sata, Michio ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KURUME UNIVERSITY HOSPITAL   (Japan)

Author keywords

Mental stress; Physical stress; Quality of life; Starvation; Supplementation

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CALORIC INTAKE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIET RESTRICTION; DIET SUPPLEMENTATION; FATIGUE; FEMALE; HUMAN; HUNGER; LIVER CIRRHOSIS; LIVER FUNCTION; MALE; MALNUTRITION; MENTAL STRESS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUTRITIONAL STATUS; NUTRITIONAL SUPPORT; PHYSICAL STRESS; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SELF EVALUATION; SEX DIFFERENCE;

EID: 55449102974     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2008.00390.x     Document Type: Article

References (37)

1. Plauth M, Cabre E, Riggio O et al. ESPEN guidelines on enteral nutrition: Liver disease. Clin Nutr 2006; 25: 285-94.
2. Force ABoDatCGT. Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. JPEN J Parenter Enteral Nutr 2002; 26: 1SA-138SA.
3. Kawamura N, Nakajima H, Takashi SI. Administration of granulated BCAA and quality of life. Hepatol Res 2004; 30S: 42-5.
4. Yoshida T, Muto Y, Moriwaki H, Yamato M. Effect of long-term oral supplementation with branched-chain amino acid granules on the prognosis of liver cirrhosis. Gastroenterol Jpn 1989; 24: 692-8.
5. Cabre E, Gonzalez-Huix F, Abad-Lacruz A et al. Effect of total enteral nutrition on the short-term outcome of severely malnourished cirrhotics. A randomized controlled trial. Gastroenterology 1990; 98: 715-20.
6. Kearns PJ, Young H, Garcia G et al. Accelerated improvement of alcoholic liver disease with enteral nutrition. Gastroenterology 1992; 102: 200-5.
7. Le Cornu KA, McKiernan FJ, Kapadia SA, Neuberger JM. A prospective randomized study of preoperative nutritional supplementation in patients awaiting elective orthotopic liver transplantation. Transplantation 2000; 69: 1364-9.
8. Suzuki K, Kato A, Iwai M. Branched-chain amino acid treatment in patients with liver cirrhosis. Hepatol Res 2004; 30S: 25-9.
9. Muto Y, Sato S, Watanabe A et al. Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis. Clin Gastroenterol Hepatol 2005; 3: 705-13.
10. Sato S, Watanabe A, Muto Y et al. Clinical comparison of branched-chain amino acid (l-Leucine, l-Isoleucine, l-Valine) granules and oral nutrition for hepatic insufficiency in patients with decompensated liver cirrhosis (LIV-EN study). Hepatol Res 2005; 31: 232-40.
11. Muto Y, Sato S, Watanabe A et al. Overweight and obesity increase the risk for liver cancer in patients with liver cirrhosis and long-term oral supplementation with branched-chain amino acid granules inhibits liver carcinogenesis in heavier patients with liver cirrhosis. Hepatol Res 2006; 35: 204-14.
12. Owen OE, Reichle FA, Mozzoli MA et al. Hepatic, gut, and renal substrate flux rates in patients with hepatic cirrhosis. J Clin Invest 1981; 68: 240-52.
13. Owen OE, Trapp VE, Reichard GA Jr et al. Nature and quantity of fuels consumed in patients with alcoholic cirrhosis. J Clin Invest 1983; 72: 1821-32.
14. Swart GR, Zillikens MC, van Vuure JK, van den Berg JW. Effect of a late evening meal on nitrogen balance in patients with cirrhosis of the liver. BMJ 1989; 299: 1202-3.
15. Gores GJ, Wiesner RH, Dickson ER, Zinsmeister AR, Jorgensen RA, Langworthy A. Prospective evaluation of esophageal varices in primary biliary cirrhosis: Development, natural history, and influence on survival. Gastroenterology 1989; 96: 1552-9.
16. Tong MJ, el-Farra NS, Reikes AR, Co RL. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 1995; 332: 1463-6.
17. Lai CL, Yuen MF. The natural history and treatment of chronic hepatitis B: A critical evaluation of standard treatment criteria and end points. Ann Intern Med 2007; 147: 58-61.
18. Barrett BJ, Parfrey PS, Vavasour HM, O'Dea F, Kent G, Stone E. A comparison of nonionic, low-osmolality radiocontrast agents with ionic, high-osmolality agents during cardiac catheterization. N Engl J Med 1992; 326: 431-6.
19. Rolls BJ, Rolls ET, Rowe EA, Sweeney K. Sensory specific satiety in man. Physiol Behav 1981; 27: 137-42.
20. Kawaguchi T, Taniguchi E, Itou M et al. Appearance-specific satiety increases appetite and quality of life in patients with metastatic liver tumor: A case report. Kurume Med J 2006; 53: 41-6.
21. Rolls BJ, Rowe EA, Rolls ET, Kingston B, Megson A, Gunary R. Variety in a meal enhances food intake in man. Physiol Behav 1981; 26: 215-21.
22. Shimoyama Y, Kusano M, Kuwamura O et al. High-viscosity liquid meal accelerates gastric emptying. Neurogastroenterol Motil 2007; 879-86.
23. Nakaya Y, Okita K, Suzuki K et al. BCAA-enriched snack improves nutritional state of cirrhosis. Nutrition 2007; 23: 113-20.
24. Reibel DK, Greeson JM, Brainard GC, Rosenzweig S. Mindfulness-based stress reduction and health-related quality of life in a heterogeneous patient population. Gen Hosp Psychiatry 2001; 23: 183-92.
25. Greco CM, Rudy TE, Manzi S. Effects of a stress-reduction program on psychological function, pain, and physical function of systemic lupus erythematosus patients: A randomized controlled trial. Arthritis Rheum 2004; 51: 625-34.
26. Fernstrom JD, Fernstrom MH. Exercise, serum free tryptophan, and central fatigue. J Nutr 2006; 136: 553S-9S.
27. Davis JM, Alderson NL, Welsh RS. Serotonin and central nervous system fatigue: Nutritional considerations. Am J Clin Nutr 2000; 72: 573S-8S.
28. Martins C, Morgan LM, Bloom SR, Robertson MD. Effects of exercise on gut peptides, energy intake and appetite. J Endocrinol 2007; 193: 251-8.
29. Kojima M, Kangawa K. Drug insight: The functions of ghrelin and its potential as a multitherapeutic hormone. Nat Clin Pract Endocrinol Metab 2006; 2: 80-8.
30. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646-9.
31. Kamath PS, Wiesner RH, Malinchoc M et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464-70.
32. Gunsar F, Raimondo ML, Jones S et al. Nutritional status and prognosis in cirrhotic patients. Aliment Pharmacol Ther 2006; 24: 563-72.
33. Swart GR, van den Berg JW, Wattimena JL, Rietveld T, van Vuure JK, Frenkel M. Elevated protein requirements in cirrhosis of the liver investigated by whole body protein turnover studies. Clin Sci (Lond.) 1988; 75: 101-7.
34. Ijichi C, Matsumura T, Tsuji T, Eto Y. Branched-chain amino acids promote albumin synthesis in rat primary hepatocytes through the mTOR signal transduction system. Biochem Biophys Res Commun 2003; 303: 59-64.
35. Muller MJ, Bottcher J, Selberg O et al. Hypermetabolism in clinically stable patients with liver cirrhosis. Am J Clin Nutr 1999; 69: 1194-201.
36. Kawaguchi T, Yoshida T, Harada M et al. Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3. Am J Pathol 2004; 165: 1499-508.
37. Itou M, Kawaguchi T, Taniguchi E et al. Altered Expression of Glucagon-Like Peptide-1 and Dipeptidyl Peptidase IV in Patients with HCV-related Glucose Intolerance. J Gastroenterol Hepatol 2008; 23: 224-51.